Adherence to the Swiss guidelines for management of COPD: Experience of a Swiss Teaching Hospital

Swiss Medical Weekly

Volumn 135, Issue 7-8, 2005, Pages 116-121

  Fritsch, K ^a   Jacot, M L ^a   Klarer, A ^a   Wick, F ^a   Bruggmann, P ^a   Krause, M ^a   Thurnheer, Robert ^a,b  

^a Kantonsspital Muensterlingen   (Switzerland)

^b Leitender Arzt Pneumol Kantonssp   (Switzerland)

Author keywords

COPD; Diagnosis; Prevention; Swiss guidelines; Treatment

Indexed keywords

ACETYLCYSTEINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; NICOTINE; PNEUMOCOCCUS VACCINE; TIOTROPIUM BROMIDE;

ADULT; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL OBSERVATION; DISEASE EXACERBATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; NICOTINE REPLACEMENT THERAPY; OXYGEN THERAPY; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PUBLICATION; QUESTIONNAIRE; REVIEW; SMOKING CESSATION; SPIROMETRY; SWITZERLAND; TEACHING HOSPITAL; WALKING;

EID: 14744283318     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
2. Miravitlles M. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J 2002;20:243-44.
3. Russi EW, Leuenberger P, Brandli O, Frey JG, Grebski E, Gugger M, et al. Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society. Swiss Med Wkly 2002;132:67-78.
4. Leuenberger P, Anderhub HP, Brandli O, Keller R, Knoblauch A, Kuhn M, et al. Management 1997 of chronic obstructive pulmonary disease. Working Group of the Swiss Society of Pneumology. Schweiz Med Wochenschr 1997;127:766-82.
5. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report Bethesda, National Heart, Lung and Blood Institute, April 2001; (NIH Publication No. 2701:1-100).
6. Bailey R, Weingarten S, Lewis M, Mohsenifar Z. Impact of clinical pathways and practice guidelines on the management of acute exacerbations of bronchial asthma. Chest 1998;113:28-33.
7. Roche N, Lepage T, Bourcereau J, Terrioux P. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J 2001;18:903-8.
8. Hackner D, Tu G, Weingarten S, Mohsenifar Z. Guidelines in pulmonary medicine: a 25-year profile. Chest 1999;116:1046-62.
9. Pauwels RA. National and international guidelines for COPD: the need for evidence. Chest 2000;117(2 Suppl):20S-22S.
10. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
11. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999;160:1248-53.
12. Wedzicha JA, Bestall JC, Garrod R, Garnham R, Paul EA, Jones PW. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J 1998;12:363-9.
13. Berry JK, Baum CL. Malnutrition in chronic obstructive pulmonary disease: adding insult to injury. AACN Clin Issues 2001;12:210-9.
14. Celli BR, MacNee W, and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
15. Murray CJ, Lopez AD. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science 1996;274:740-3.
16. Is 12-hour oxygen as effective as 24-hour oxygen in advanced chronic obstructive pulmonary disease with hypoxemia? (The nocturnal oxygen therapy trial - NOTT). Chest 1980;78:419-20.
17. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997;155:1283-9.
18. Jackevicius C, Joyce DP, Kesten S, Chapman KR. Prehospitalization inhaled corticosteroid use in patients with COPD or asthma. Chest 1997;111:296-302.
19. Van Andel AE, Reisner C, Menjoge SS, Witek TJ. Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995. Chest 1999;115:703-7.
20. Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences. Chest 2000;117(2Suppl):33S-37S.
21. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004;23:28-33.
22. Wilkinson TMA, Donaldson GC, Hurst JR, Seemugal TAR, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169:1298-1303.
23. Fabbri LM, Hurd SS, for the GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003;22:1-2.
24. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003;124:1743-8.
25. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2003;361:449-56.
26. Sutherland ER, Chermiack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 2004;350:2689-97.
27. Schols AM, Wesseling G, Kester AD, de Vries G, Mostert R, Slangen J, et al. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. Eur Respir J 2001;17:337-42.
28. Russi EW, Anderhub HP, Bloch K, Speich R. [Experiences with long-term transtracheal oxygen therapy]. Schweiz Rundsch Med Prax 1990;79:850-3.
29. Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002;(3):CD003793.
30. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000;161:381-90.